Literature DB >> 10885578

The pleiotropic effects of fibroblast growth factor receptors in mammalian development.

I McIntosh1, G A Bellus, E W Jab.   

Abstract

In recent years the study of fibroblast growth factor receptors (FGFRs) in normal development and human genetic disorders has increased our understanding of some complex cellular processes. At least fifteen genetic disorders result from mutations within FGFR genes including skeletal dysplasias such as Apert syndrome and achondroplasia. In vitro experiments and the generation of animal models indicate that these mutations result in activation of the receptors and that FGFRs act as negative regulators of bone growth. FGFRs also play a role in wound healing and cancer. In this article, we review the expression of FGFRs in human development, the phenotypes resulting from FGFR mutations, and recent data identifying pathways downstream of the activated receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885578     DOI: 10.1247/csf.25.85

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  21 in total

Review 1.  FGF signalling: diverse roles during early vertebrate embryogenesis.

Authors:  Karel Dorey; Enrique Amaya
Journal:  Development       Date:  2010-11       Impact factor: 6.868

2.  Enhanced cell-cell contact stability and decreased N-cadherin-mediated migration upon fibroblast growth factor receptor-N-cadherin cross talk.

Authors:  Thao Nguyen; Laurence Duchesne; Gautham Hari Narayana Sankara Narayana; Nicole Boggetto; David D Fernig; Chandrashekhar Uttamrao Murade; Benoit Ladoux; René-Marc Mège
Journal:  Oncogene       Date:  2019-07-16       Impact factor: 9.867

3.  Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.

Authors:  O A Ibrahimi; A V Eliseenkova; A N Plotnikov; K Yu; D M Ornitz; M Mohammadi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

4.  Pathogenic Cysteine Removal Mutations in FGFR Extracellular Domains Stabilize Receptor Dimers and Perturb the TM Dimer Structure.

Authors:  Sarvenaz Sarabipour; Kalina Hristova
Journal:  J Mol Biol       Date:  2016-09-03       Impact factor: 5.469

5.  Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis.

Authors:  P Bellosta; A Iwahori; A N Plotnikov; A V Eliseenkova; C Basilico; M Mohammadi
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  The A391E mutation enhances FGFR3 activation in the absence of ligand.

Authors:  Fenghao Chen; Catherine Degnin; Melanie Laederich; William A Horton; Kalina Hristova
Journal:  Biochim Biophys Acta       Date:  2011-04-22

Review 7.  Physical-chemical principles underlying RTK activation, and their implications for human disease.

Authors:  Lijuan He; Kalina Hristova
Journal:  Biochim Biophys Acta       Date:  2011-08-05

8.  Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.

Authors:  Brian K Yeh; Anna V Eliseenkova; Alexander N Plotnikov; David Green; Jared Pinnell; Tulay Polat; Amel Gritli-Linde; Robert J Linhardt; Moosa Mohammadi
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  Lens fiber cell differentiation occurs independently of fibroblast growth factor receptor signaling in the absence of Pten.

Authors:  Stephanie L Padula; Elaine P Sidler; Brad D Wagner; Courtney J Manz; Frank J Lovicu; Michael L Robinson
Journal:  Dev Biol       Date:  2020-08-25       Impact factor: 3.582

Review 10.  Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology.

Authors:  Artur A Belov; Moosa Mohammadi
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.